E-mail:BD@ebraincase.com
Tel:+8618971215294
English 中文版
Virus Vector - Viral Vector Production - BrainCaseVirus Vector - Viral Vector Production - BrainCase
  • Home
  • Virus product library
    CRISPRRNAiHSV-helperRV-helperNeurophilic virusCalcium SensorsOptogenetics activationOptogenetics inhibitionChemical geneticsSparse labelingFluorescent proteinBiosensorsRecombinaseApoptosis & AutophagyDisease ModelNeurotoxicityOther
  • Products & Service

    Product Center

    Virus

    VSV-vaccine and gene therapy research
    Retrovirus-RCAS-TVA
    Lentivirus Vector-Lentivirus Production
    Rabies Virus Vector-RBV Vector
    Herpes simplex virus-Oncolytic and anterograde tracing
    PRV-retrograd multisynaptic-Peripheral
    AAV-gene therapy vectors-neuroscience

    Animal Model

    Neurological Disease Models
    Tumor animal models-anti-tumor
    Digestive System Disease Animal Model
    Cardiovascular System Disease Animal Models

    Plasmid Construction

    Library Construction
    Plasmid design and construction

    Popular Applications

    Gene Regulation

    Gene Overexpression-Brain Case
    RNA interference(RNAi)-siRNA-Brain Case
    Gene Editing - CRSIPR cloning - BrainCase

    Neural Circuit Function Research

    Optogenetics - BrainCase
    Chemical genetics-DREADDs-Brain Case
    Calcium signal recording-Gels- Brain Case
    GRAB Neurotransmitter Fluorescent Sensor- Brain Case
    Functional Magnetic Resonance Imaging Technology- Brain Case

    Research on the structure of neural circuits

    Direct Input and Output-viral vectors- Brain Case
    Anterograde Mono-synaptic Tracing -HSV- Brain Case
    Antrograde Muti-synaptic Tracing-HSV & VSV-Brain Case
    Retrograde Mono-synaptic Tracing-Rabies Virus-Brain Case
    Retrograde Muti-synaptic Tracing-PRV-Brain Case

    Featured Services

    Nervous System Disease Drug Effect

    Alzheimer's disease-AD
    Depression-mental disorders
    Parkinson's disease--PD
    Epilepsy-an ancient neurological disorder

    AAV Serotype Screening

    AAV Serotypes screening-gene therapy

    Tumorigenicity Test

    Tumorigenicity Testing-Evaluation of tumor models

    Efficacy of Oncolytic Virus

    Oncolytic virus-for cancer therapy-Brain Case
    Herpes Virus Vector-anti-tumor- BrainCase
    Vesicular stomatitis virus-killing tumor cells-Brain Case
  • News
    Corporate News New Product Launch Media Activity Investor News
  • Support
    Literature interpretation Customer article Video Zone FAQs
  • About Us
    Virus product library Products & Service News Support About Us Contact
  • Contact
    Contact Us Join us
  • 中文
    English 中文版
  • Home
  • News
  • New Product Launch
  • News
  • Corporate News
  • New Product Launch
  • Media Activity
  • Investor News

[Research Tool Highlight] Featured in Cell! Brain Case launches new product — Enhancer AAV Vectors, a breakthrough for research Tool !

Time:2025-08-26 16:59:09
 
The mammalian brain, as a highly complex organ, contains a cortex composed of hundreds of distinct cell types. These cells can be classified in multiple dimensions based on shared morphological features, functional properties, and molecular expression profiles. Defining the contribution of each cell type to cortical physiological processes is critical for understanding their roles in both health and disease.

On May 29, 2025, a major milestone of the U.S. NIH BRAIN Initiative was published in Cell. The paper, titled “A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types”, reports that researchers utilized transcriptomic and epigenomic classifications of mouse and human cortical cell types to define marker genes and putative enhancers. They created a large toolkit comprising 15 transgenic driver mouse lines, 2 reporter lines, and over 1,000 enhancer AAV vectors designed for specific targeting of cortical subpopulations, with some tools achieving over 90% specificity.

https://www.cell.com/cell/fulltext/S0092-8674(25)00513-6

 
All tools have been made available through Addgene and Jackson Labs. Experimental data related to SYFP2 expression vectors in this study can be accessed via the Genetic Tools Atlas network portal — a new public resource developed by the Allen Institute (RRID:SCR_025643; https://portal.brain-map.org/genetic-tools/genetic-tools-atlas) and BioFileFinder (BFF) (RRID:SCR_026930; https://bff.allencell.org/), which also includes datasets from individual scRNA-seq experiments.

Figure 1. Two strategies for generating and characterizing genetic tools.
 

Enhancer AAV Vector Screening and Optimization

Researchers built a cross-species (mouse/human) transcriptomic and epigenomic taxonomy at sub-class resolution by integrating historical genomic datasets with newly generated single-nucleus multiomic data (snMultiome). Mouse data were obtained from the primary somatosensory area (SSp), primary motor area (MOp), and primary visual area (VISp), while human data were collected from the middle temporal gyrus (MTG).

These approaches enabled the measurement of tens of thousands of molecular features in single cells, classification into molecularly defined cell types, and identification of marker genes and genomic enhancers consistent with specific cell types. Based on these findings, researchers designed and tested 1,164 unique enhancer AAV vectors, including 802 candidate sequences (643 mouse-derived and 159 human-derived). Approximately 40% (313 vectors) demonstrated targeting specificity.

Each putative enhancer sequence was assigned a unique ID: AiE = enhancers discovered by the Allen Institute.  ExE = sequences based on coordinates reported by other research groups. The IDs are followed by four digits and a species identifier (“m” for mouse, “h” for human). Candidate enhancer sequences were amplified from their respective genomes and cloned upstream of a minimal promoter (minBG, minRho, minCMV) or an endogenous promoter in an AAV plasmid backbone, driving the expression of yellow fluorescent protein SYFP.

Figure 2. Enhancer AAV vector information on Addgene
(https://www.addgene.org/browse/article/28248370/)
 
The plasmids were packaged into PHP.eB AAV vectors, capable of crossing the blood-brain barrier, and delivered to C57BL/6J mice via retro-orbital (RO) injection. About four weeks post-injection, brain slice fluorescence images were first screened visually, followed by serial two-photon tomography (STPT) for whole-brain labeling assessment, and single-cell RNA sequencing (scRNA-seq) for determining cell-type specificity. Experiments focused on the mouse visual cortex to ensure data consistency.

Through core deletion and tandem optimization, SYFP2 mRNA expression levels from enhancer AAVs increased by an average of 839%, while maintaining stable specificity. Recombinase versions (e.g., Cre, FlpO) were also developed, with modifications such as Cre(R297T) mutation and adjustments to WPRE sequences to reduce off-target expression.

Figure 3. Screening enhancer AAVs in the mouse brain
 
The most valuable tools—those enabling genetic access to specific sub-classes or clusters—were designated with a “Hall of Fame” (HoF) label. This naming, manually assigned by Allen Institute scientists, considers factors such as specificity determined from scRNA-seq data and signal intensity of enhancer AAVs, helping researchers identify the best tools for targeting defined cell populations.

Figure 4. Hall of Fame (HoF) enhancer AAVs

 

Establishment of Transgenic Driver and Reporter Mouse Lines

Finally, researchers established and evaluated 15 transgenic driver mouse lines and 2 reporter lines, which can be used either independently or in combination with enhancer AAVs to achieve genetic access to even the most finely classified cortical subpopulations.
The two reporter lines (Ai193 and Ai224) contain independent transcription units that report the expression of Cre and Flp recombinases by expressing different fluorescent proteins:
Ai193: TICL-EGFP-WPRE-ICF-tdT-WPRE-hyg
Ai224: TICL-NLS-EGFP-ICF-NLS-dT-hyg

In these lines: GFP is expressed when Cre is present, tdTomato is expressed when Flp is present, Both fluorescent proteins are expressed simultaneously when Cre and Flp are co-expressed.
Based on the transcriptomic taxonomy of mouse cortical cell types, marker genes capable of labeling specific cell types (subclasses, supertypes, or clusters) were selected. Fifteen genes were chosen to generate Cre or Flp driver lines.

Glutamatergic driver lines: 11 marker genes were used, including Batf3, Parm1, Rxfp1, Chrna6, Slco2a1, Cplx3, Cpne4, Ctxn3, Gpr139, Npnt, and Slc17a7.
·Batf3-IRES2-FlpO-WPRE-neo primarily targeted the L5_IT_VISp_Batf3 cluster within the L5_IT subclass, but also labeled some L2/3 IT, other L5_IT, L6_CT cells, and microglia.
·Chrna6-IRES2-FlpO specifically labeled the L5_ET_Chrna6 cell type.

GABAergic driver lines: genes such as Lamp5, Sncg, and Chodl were used to construct driver lines.
·Lamp5-P2A-FlpO labeled Lamp5 GABAergic neurons but also labeled glutamatergic cells in layers 2–3, 5, and 6.
·Sncg-IRES-FlpO;Ai65F labeled the Sncg neuronal population as well as endothelial cells.

Figure 5. Comparison of transgenic reporter and driver mouse lines with selected enhancer AAVs.
 

Significance of the Study

This article reports the creation and public release of over 1,000 enhancer AAVs and 17 transgenic mouse lines as genetic tools. Their specificity was validated through single-cell sequencing and imaging technologies, and further optimized to improve performance. By establishing a cross-species cortical cell taxonomy, the study provides a standardized toolkit and data resource for cortical cell-type research, advancing our understanding of brain function and disease mechanisms. Moreover, the large-scale development workflow sets a methodological foundation for future innovations in neuroscience tool development.
Original article: https://doi.org/10.1016/j.cell.2025.05.002

 
The following table was compiled by the Brain Case Team, with information sourced from the supplementary materials of DOI: 10.1016/j.cell.2025.05.002. If you are interested in the related vectors, please feel free to contact us. bd@ebraincase.com

 

Service Type :

Select the service you'd like to purchase.

Order Information(Premade-AAVs)

Please provide us some information about the service you'd like to order.

How did you hear about BrainCase Biotech or our products?

Detailed requirements:

scroll

Order Information(Custom AAV/Lentivirus)

Please provide us some information about the service you'd like to order.

Gene ID or gene information:

Selection of the reporting gene:

Special Instructions:

scroll

Order Information(Others)

Please provide us some information about the service you'd like to order.

Virus name/Detailed requirements:

scroll

Related products

[Research Tool Highlight] Featured in Cell! Brain Case launches new product — Enhancer AAV Vectors, a breakthrough for  research Tool !

[Research Tool Highlight] Featured in Cell! Brain Case launches new product — Enhancer AAV Vectors, a breakthrough for research Tool !

Brain Case New Arrival | Novel High-Brightness Red PRV Virus – A Powerful Tool for Peripheral Nervous System Research

Brain Case New Arrival | Novel High-Brightness Red PRV Virus – A Powerful Tool for Peripheral Nervous System Research

Breakthrough! The next-generation GABA sensor iGABASnFR2 and glutamate sensors iGluSnFR4f/4s enable high-sensitivity analysis of synaptic dynamics!

Breakthrough! The next-generation GABA sensor iGABASnFR2 and glutamate sensors iGluSnFR4f/4s enable high-sensitivity analysis of synaptic dynamics!

Nature Methods|mYongHong: A New Generation of Ultra-Stable Monomeric Red Fluorescent Protein

Nature Methods|mYongHong: A New Generation of Ultra-Stable Monomeric Red Fluorescent Protein

map
{dede:global.cfg_webname/}

Virus product library

CRISPR
RNAi
Neurophilic virus
Optogenetics activation
Biosensors

News

Corporate News
New Product Launch
Media Activity
Investor News

Support

Literature interpretation
Customer article
Video Zone
FAQs
微信

WhatsApp Business Account

Tel: +8618971215294
E-mail: BD@ebraincase.com

Address:-

Address:-

  • Copyright © 2024 Brain Case All Rights Reserved.